Seguir
Louise Abenan Ouattara
Louise Abenan Ouattara
Dirección de correo verificada de evms.edu
Título
Citado por
Citado por
Año
Novel human reovirus isolated from children with acute necrotizing encephalopathy
LA Ouattara, F Barin, MA Barthez, B Bonnaud, P Roingeard, A Goudeau, ...
Emerging infectious diseases 17 (8), 1436, 2011
1002011
MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection
LA Ouattara, P Barnable, P Mawson, S Seidor, TM Zydowsky, L Kizima, ...
Antimicrobial agents and chemotherapy 58 (5), 2841-2848, 2014
272014
Seminal exosomes and HIV‐1 transmission
LA Ouattara, SM Anderson, GF Doncel
Andrologia 50 (11), e13220, 2018
232018
A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants
P Barnable, G Calenda, L Ouattara, A Gettie, J Blanchard, N Jean-Pierre, ...
PLoS One 9 (9), e108109, 2014
192014
Genital mucosal drug concentrations and anti-HIV activity in tenofovir-based PrEP Products: intravaginal ring vs. oral administration
LA Ouattara, AR Thurman, TA Jacot, M Cottrell, C Sykes, K Blake, X Fang, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 89 (1), 87-97, 2022
102022
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used …
AR Thurman, V Brache, L Cochon, LA Ouattara, N Chandra, T Jacot, ...
PloS one 17 (10), e0275794, 2022
82022
Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using a 90-day tenofovir/levonorgestrel vaginal ring
AR Thurman, J Ravel, P Gajer, MA Marzinke, LA Ouattara, T Jacot, ...
Frontiers in Cellular and Infection Microbiology 12, 799501, 2022
82022
A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir
AR Thurman, LA Ouattara, N Yousefieh, PL Anderson, LR Bushman, ...
Frontiers in Cellular and Infection Microbiology 13, 1130101, 2023
52023
Single-administration long-acting microarray patch with ultrahigh loading capacity and multiple releases of thermally stable antibodies
KTM Tran, TT Le, V Agrahari, MM Peet, LA Ouattara, SM Anderson, ...
Molecular Pharmaceutics 20 (5), 2352-2361, 2023
32023
Synthesis and evaluation of anti-HIV activity of mono-and di-substituted phosphonamidate conjugates of Tenofovir
A Qureshi, LA Ouattara, NS El-Sayed, A Verma, GF Doncel, ...
Molecules 27 (14), 4447, 2022
32022
Ex vivo HIV infection model of cervico-vaginal and rectal tissue
LA Ouattara, NC Vann, GF Doncel
HIV Reservoirs: Methods and Protocols, 157-172, 2022
32022
HIV prevention in healthy women: safety and pharmacokinetics of a potential new tenofovir alafenamide fumarate (TAF)-based oral prep regimen
JL Schwartz, AR Thurman, V Brache, BA Chen, L Cochon, SH Ju, ...
AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 56-56, 2018
32018
Les orthoréovirus: virus orphelins ou pathogènes chez l’homme?
L Ouattara, G Paranhos-Baccalà, F Komurian-Pradel
Virologie 12 (4), 249-260, 2008
22008
Anti-HIV activity and drug concentrations in tenofovir-based products: intravaginal ring versus oral tablet
SH Ju, LA Ouattara, AR Thurman, ML Cottrell, GF Doncel, JL Schwartz
AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 343-343, 2018
12018
Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used …
NR Mugo, V Mudhune, R Heffron, KK Thomas, E McLellan-Lemal, ...
Frontiers in Reproductive Health 5, 1118030, 2023
2023
Genital mucosal drug concentrations and anti-HIV activity in tenofovir-based PrEP products: intravaginal ring versus oral administration
LA Ouattara, AR Thurman, TA Jacot, M Cottrell, C Sykes, K Blake, X Fang, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2021
2021
A MIV-150
P Barnable, G Calenda, L Ouattara, A Gettie, J Blanchard
Zinc Acetate Gel Inhibits SHIV-RT Infection in Macaque Vaginal, 2014
2014
Orthoreoviruses: are they pathogenic in human?
L Ouattara, G Paranhos-Baccala, F Komurian-Pradel
VIROLOGIE 12 (4), 249-260, 2008
2008
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–18